Loading...
SMAD4 promotes TGF-β–independent NK cell homeostasis and maturation and antitumor immunity
SMAD4 is the only common SMAD in TGF-β signaling that usually impedes immune cell activation in the tumor microenvironment. However, we demonstrated here that selective deletion of Smad4 in NK cells actually led to dramatically reduced tumor cell rejection and augmented tumor cell metastases, reduce...
Saved in:
| Published in: | J Clin Invest |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society for Clinical Investigation
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6205382/ https://ncbi.nlm.nih.gov/pubmed/30183689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI121227 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|